Richard William Scalzo
Chief Financial Officer · CRESCENT BIOPHARMA, INC.
- 2024
- Sep 18, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard William Scalzo files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $20.00M in CBIO purchases and sales in the last 12 months
- Joshua T. Brumm - $921K in CBIO purchases and sales in the last 12 months
- Jonathan McNeill - $447K in CBIO purchases and sales in the last 12 months
- Jan Pinkas - $35K in CBIO purchases and sales in the last 12 months
- Ellie Eunkyung Im - $33K in CBIO purchases and sales in the last 12 months
- Barbara Harlin Bispham - $33K in CBIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard William Scalzo?
Richard William Scalzo is a corporate insider, tracked as Chief Financial Officer of CRESCENT BIOPHARMA, INC. (CBIO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard William Scalzo submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Richard William Scalzo been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($148K) across all tracked filings.
